SCHEMBL30926850

SCHEMBL30926850

Cc1cccc(NC(=O)c2cccc(NS(=O)(=O)c3ccc(Cl)cc3)c2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.71
KMT2A Q03164 7/20 0.71
EGFR P00533 5/20 0.67
FGFR1 P11362 5/20 0.67
KDR P35968 5/20 0.67
KCNK3 O14649 3/20 0.65
MAPT P10636 3/20 0.61
CYP1A2 P05177 2/20 0.61
CYP3A4 P08684 2/20 0.61
CYP2D6 P10635 2/20 0.61
CYP2C9 P11712 2/20 0.61
CYP2C19 P33261 2/20 0.61
HTT P42858 2/20 0.61
RECQL P46063 1/20 0.61
RXFP1 Q9HBX9 1/20 0.60
KCNK9 Q9NPC2 2/20 0.60
CYP19A1 P11511 1/20 0.58
GAA P10253 1/20 0.58
LMNA P02545 1/20 0.58
KCNH2 Q12809 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179824 1.00 MEN1 (0.71) MEN1KMT2AEGFRFGFR1KDR
SCHEMBL30927044 0.91 MEN1 (0.76) MEN1KMT2AEGFRFGFR1KDR
SCHEMBL27179714 0.91 MEN1 (0.76) MEN1KMT2AEGFRFGFR1KDR
SCHEMBL30926654 0.86 TCF4 (0.69) MEN1KMT2AEGFRFGFR1KDR
SCHEMBL27180756 0.86 TCF4 (0.69) MEN1KMT2AEGFRFGFR1KDR
SCHEMBL26463794 0.86 CYP19A1 (0.78) MEN1KMT2AMAPTHTTCYP19A1
SCHEMBL30926705 0.85 KMT2A (0.70) MEN1KMT2AEGFRFGFR1KDR
SCHEMBL27179849 0.85 KMT2A (0.70) MEN1KMT2AEGFRFGFR1KDR
SCHEMBL21802493 0.83 CYP19A1 (0.69) MEN1KMT2AEGFRFGFR1KDR
SCHEMBL22863019 0.82 MEN1 (0.73) MEN1KMT2AKCNK3MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885EGFR 3152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.